LifeVantageLFVN
LFVN
About: Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Employees: 222
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
350% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 8
94% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 16
63% more call options, than puts
Call options by funds: $379K | Put options by funds: $233K
36% more funds holding
Funds holding: 77 [Q4 2024] → 105 (+28) [Q1 2025]
29% more capital invested
Capital invested by funds: $72.9M [Q4 2024] → $93.9M (+$21M) [Q1 2025]
18.15% more ownership
Funds ownership: 33.2% [Q4 2024] → 51.34% (+18.15%) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for LFVN.
Financial journalist opinion
Neutral
Seeking Alpha
1 month ago
LifeVantage Corporation (LFVN) Q3 2025 Earnings Call Transcript
LifeVantage Corporation (NASDAQ:LFVN ) Q3 2025 Results Conference Call May 6, 2025 4:30 PM ET Company Participants Reed Anderson - Managing Director-ICR Steve Fife - President and Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by.
Neutral
GlobeNewsWire
1 month ago
LifeVantage Declares Quarterly Dividend
SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid June 13, 2025 to all stockholders of record at the close of business on May 30, 2025. This represents an increase in the dividend amount by 12.5% over the previous quarter.
Neutral
GlobeNewsWire
1 month ago
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2025
SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2025. Third Quarter Fiscal 2025 Summary*: Revenue was $58.4 million, an increase of 21.1% from the prior year period.
Positive
Seeking Alpha
1 month ago
LifeVantage: Activation Of Shareholder Value
LifeVantage (LFVN) is a mispriced opportunity with potential for >15% IRR, driven by its new GLP-1 product suite and turnaround signals. LFVN's valuation is attractive at ~6x EV/EBITDA and a Fwd PEG of 0.15x, trading below sector median despite strong growth potential. The company's revamped business model and compensation package have increased active accounts by 25%, indicating early signs of success turnaround and enhanced sales outreach which the market is not reacting.
Neutral
GlobeNewsWire
1 month ago
Global Convention 2025 Empowers Consultants to ‘Go Further' with Exclusive Trainings, Product Announcements, and New Incentives to Drive Growth
SALT LAKE CITY, April 28, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion of their annual Global Convention, held April 24-26, 2025, in Salt Lake City, Utah. Thousands of independent LifeVantage Consultants from around the world gathered at the Salt Palace Convention Center to participate in the multi-day event.
Neutral
GlobeNewsWire
1 month ago
LifeVantage to Announce Third Quarter Fiscal Year 2025 Results on May 6, 2025
SALT LAKE CITY, April 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2025, after the stock market closes on Tuesday, May 6, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Neutral
GlobeNewsWire
2 months ago
LifeVantage Expands Global Reach with International Launch of the MB System™
SALT LAKE CITY, March 17, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation ® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is extending its groundbreaking MindBody GLP-1 System™ to international markets. This expansion comes after a 49% year-over-year increase in fiscal Q2 revenue ending December 31, 2024, in the U.S., largely driven by the system's success, and clinical data on that formula reinforcing its effectiveness in supporting GLP-1 production.
Neutral
GlobeNewsWire
3 months ago
LifeVantage Announces Launch of LV360 and Evolve Compensation Plan in Philippines, Taiwan, Hong Kong, and Singapore Markets
SALT LAKE CITY, March 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation ® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful launch of the Evolve Compensation Plan and other LV360 initiatives into the Philippines, Taiwan, Hong Kong, and Singapore. The transition went into effect in these markets on March 1, 2025, after the successful launch of LV360 into Canada, Mexico, and Europe last February, and the launch in the US, Australia, New Zealand and Japan in March 2023.
Positive
MarketBeat
4 months ago
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector. These treatments are permitted when drugs are listed on the FDA's list of drug shortages.
Positive
Seeking Alpha
4 months ago
LifeVantage: Post-Earnings Selloff Provides Buying Opportunity
LifeVantage Corporation's Q2/FY2025 results were boosted by the successful launch of the MindBody GLP-1 system. LFVN revenues jumped by more than 40% on a sequential basis, while free cash flow of $8.7 million represented a new multi-year high. However, elevated commissions and incentive expenses impacted profitability, thus resulting in a rather mediocre Adjusted EBITDA margin of 9.6%.
Charts implemented using Lightweight Charts™